Petlife Pharmaceuticals Inc. | Balance Sheet
Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
-
6.90
-
1.20
54.30
Total Accounts Receivable
-
10.60
4.80
-
-
Other Current Assets
-
-
-
-
0.80
Total Current Assets
-
17.40
4.80
1.20
55.00
Intangible Assets
-
-
0.60
-
-
Total Assets
-
17.40
5.40
1.20
55.00
ST Debt & Current Portion LT Debt
138.00
-
10.00
153.00
717.20
Other Current Liabilities
535.50
-
360.50
3,083.00
719.30
Total Current Liabilities
673.50
-
370.50
3,236.00
1,436.50
Total Liabilities
673.50
-
370.50
3,236.00
1,436.50
Common Equity (Total)
704.10
17.40
365.10
3,234.90
1,384.70
Total Shareholders' Equity
704.10
17.40
365.10
3,234.90
1,381.50
Total Equity
673.50
17.40
365.10
3,234.90
1,381.50
Liabilities & Shareholders' Equity
-
17.40
5.40
1.20
55.00
Accumulated Minority Interest
1,377.60
-
-
-
-
Preferred Stock (Carrying Value)
0.00
-
-
-
3.30
About Petlife Pharmaceuticals
View Profile
